small molecule

UZEDY

RISPERIDONE

Loss of exclusivityMarch 2042latest FDA-listed patent expiry

CompanyTEVA NEUROSCIENCE INC

Drug detail

Brand name	UZEDY
Active ingredient	RISPERIDONE
Strength	150MG/0.42ML (150MG/0.42ML)
Dosage form	SUSPENSION, EXTENDED RELEASE
Route	SUBCUTANEOUS
Modality	Small molecule
FDA approval	April 2023
Marketing status	RX

Listed patents

Patent	Expires	Type
12329851	March 2042	use U-4214
12383493	September 2040	product
12128132	September 2040	product
9023897	April 2033	product
8221778	November 2027	product
8741327	November 2027	product

Regulatory exclusivity

Code	Expires
NP	April 2026

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Drug detail

Listed patents

Regulatory exclusivity

More from TEVA NEUROSCIENCE INC